Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Pleiotropic effects of antithrombin strand 1C substitution mutations
Genetic mutations in antithrombin strand 1C cause functional deficiency, leading to venous thromboembolic disease. These mutations impact antithrombin
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Antithrombin is a crucial regulator of blood coagulation, primarily inhibiting thrombin and Factor Xa.
- Functional antithrombin deficiency is linked to an increased risk of venous thromboembolic disease (VTE).
- Specific mutations in antithrombin can impair its inhibitory function and/or affect its stability and clearance.
Observation:
- Six distinct substitution mutations were identified in antithrombin strand 1C and the adjacent polypeptide region.
- These mutations were found in seven families with hereditary venous thromboembolic disease.
- Variant antithrombins exhibited heparin-binding abnormalities and, in most cases, reduced plasma antigen concentrations.
Findings:
- Purified variant antithrombins (Rosny and Torino) showed significantly reduced heparin cofactor and progressive inhibitor activities in vitro.
- Defective thrombin interaction may stem from the proximity of mutations to the reactive site.
- Reduced circulating levels might be due to proximity to conserved beta strands influencing serpin turnover and degradation.
Implications:
- Mutations in or near strand 1C have pleiotropic effects on antithrombin function, leading to VTE.
- Altered heparin binding suggests conformational linkage between the reactive site and heparin-binding regions.
- Understanding these mutations provides insights into serpin structure-function relationships and anticoagulant mechanisms.
More Related Videos
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.